Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Arginine Butyrate for Treatment of Refractory Leg Ulcers in Sickle Cell Disease or Beta Thalassemia

NCT00004412 is registered in ClinicalTrials.gov with Susan P. Perrine as lead sponsor.

NCT NCT00004412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Arginine Butyrate for Treatment of Refractory Leg Ulcers in Sickle Cell Disease or Beta Thalassemia
Lead sponsor
Susan P. Perrine
Phase
Phase 2
Overall status
Completed
Start date
September 30, 1997
Completion date
February 28, 2005
Enrollment
23 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell anemia, skin ulcers